Product
Paclitaxel + Gemcitabine
2 clinical trials
3 indications
Indication
Breast CancerIndication
Pancreatic CystIndication
EUSClinical trial
A Phase II Randomized Study of the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Physician Choice Chemotherapy in Premenopausal or Perimenopausal Patients With Hormone Receptor-positive/ HER2-negative Inoperable Locally Advanced or Metastatic Breast CancerStatus: Completed, Estimated PCD: 2022-04-12
Clinical trial
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts: a Prospective, Randomized, Double-blind, Multi-center Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-01